Bio

Bio


Dr. Hill received her Ph.D. in Clinical Psychology from Ohio University. She completed her predoctoral internship at the Veterans Affairs Palo Alto Health Care System and postdoctoral fellowship in the Psychiatry Department at the Stanford University School of Medicine where she currently serves as a Clinical Associate Professor. Dr. Hill has published articles and made presentations related to psychology training, pain management, serious mental illness including Post Traumatic Stress Disorder, and sexual dysfunction.

Dr. Hill's time is divided across clinical, research, administrative, and teaching domains. Her current adult-focused clinical interests are varied including insomnia/depression, social anxiety, relationship difficulties, and post-traumatic stress disorder. The remainder of her time is committed to psychology training as the Co-Director of Clinical Training for the PGSP-Stanford Psy.D. Consortium. On a national level, she currently serves as a Board Member of the Association of Psychology Postdoctoral and Internship Centers.

Clinical Focus


  • Psychology

Academic Appointments


  • Clinical Associate Professor, Psychiatry and Behavioral Sciences

Administrative Appointments


  • Co-Director of Clinical Training, PGSP-Stanford PsyD Consortium (2012 - Present)

Honors & Awards


  • Annual Chairman's Unsung Hero Award, Psychiatry and Behavioral Sciences, Stanford University School of Medicine (2014)
  • Mentor of the Year, Golden Apple Award, PGSP-Stanford PsyD Consortium (2014)
  • Mentor of the Year, Golden Apple Award, PGSP-Stanford PsyD Consortium (2013)
  • Mentor of the Year, Golden Apple Award, PGSP-Stanford PsyD Consortium (2011)
  • Professor of the Year, Golden Apple Award, PGSP-Stanford PsyD Consortium (2009)

Boards, Advisory Committees, Professional Organizations


  • Board Member, Association for Psychology Postdoctoral and Internship Centers (2016 - Present)

Professional Education


  • Fellowship:Stanford University School of Medicine (2004) CA
  • Medical Education:Ohio University (2002) OH
  • Internship:Palo Alto VA Healthcare System (2001) CA

Teaching

2015-16 Courses


Publications

All Publications


  • Psychotic-like Experiences, Symptom Expression, and Cognitive Performance in Combat Veterans With Posttraumatic Stress Disorder JOURNAL OF NERVOUS AND MENTAL DISEASE Lindley, S. E., Carlson, E. B., Hill, K. R. 2014; 202 (2): 91-96

    Abstract

    Apparent psychotic symptoms are often associated with posttraumatic stress disorder (PTSD), but these symptoms are poorly understood. In a sample of 30 male Vietnam combat veterans with severe and chronic PTSD, we conducted detailed assessments of psychotic symptom endorsement, insight, symptom severity, neurocognitive function, and feigning. Two thirds of the subjects endorsed a psychotic item but did not believe that the experiences were real. Those endorsing psychotic items were higher in PTSD severity, general psychopathology, and dissociation but not depression, functional health, cognitive function, or feigned effort. Severity of psychotic symptoms correlated with dissociation, combat exposure, and attention but not PTSD, depression, or functional health. Those endorsing psychotic items scored higher on a screen but not on a detailed structured interview for malingering. Endorsement of psychotic experiences by combat veterans with PTSD do not seem to reflect psychotic symptoms or outright malingering.

    View details for DOI 10.1097/NMD.0000000000000077

    View details for Web of Science ID 000336375300003

    View details for PubMedID 24469519

  • WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER COMPARED TO NORMAL FEMALES: A FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY NEUROSCIENCE Arnow, B. A., Millheiser, L., Garrett, A., Polan, M. L., Glover, G. H., Hill, K. R., Lightbody, A., Watson, C., Banner, L., Smart, T., Buchanan, T., Desmond, J. E. 2009; 158 (2): 484-502

    Abstract

    Lack of sexual interest is the most common sexual complaint among women. However, factors affecting sexual desire in women have rarely been studied. While the role of the brain in integrating the sensory, attentional, motivational, and motor aspects of sexual response is commonly acknowledged as important, little is known about specific patterns of brain activation and sexual interest or response, particularly among women. We compared 20 females with no history of sexual dysfunction (NHSD) to 16 women with hypoactive sexual desire disorder (HSDD) in a functional magnetic resonance imaging (fMRI) study that included assessment of subjective sexual arousal, peripheral sexual response using a vaginal photoplethysmograph (VPP), as well as brain activation across three time points. Video stimuli included erotic, sports, and relaxing segments. Subjective arousal to erotic stimuli was significantly greater in NHSD participants compared with HSDD. In the erotic-sports contrast, NHSD women showed significantly greater activation in the bilateral entorhinal cortex than HSDD women. In the same contrast, HSDD females demonstrated higher activation than NHSD females in the medial frontal gyrus (Brodmann area (BA) 10), right inferior frontal gyrus (BA 47) and bilateral putamen. There were no between group differences in VPP-correlated brain activation and peripheral sexual response was not significantly associated with either subjective sexual response or brain activation patterns. Findings were consistent across the three experimental sessions. The results suggest differences between women with NHSD and HSDD in encoding arousing stimuli, retrieval of past erotic experiences, or both. The findings of greater activation in BA 10 and BA 47 among women with HSDD suggest that this group allocated significantly more attention to monitoring and/or evaluating their responses than NHSD participants, which may interfere with normal sexual response.

    View details for DOI 10.1016/j.neuroscience.2008.09.044

    View details for Web of Science ID 000262959900012

    View details for PubMedID 18976696

  • The Efficacy of Cognitive Therapy, Interpersonal Therapy, and Related Psychotherapies for Depression: A Review by Treatment Phase Depression: Mind and Body Arnow, B., Hill, K. 2008; 4 (1): 15-27
  • A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY Lindley, S. E., Carlson, E. B., Hill, K. 2007; 27 (6): 677-681

    Abstract

    Topiramate, a novel anticonvulsant, has been reported to rapidly reduce symptoms of posttraumatic stress disorder (PTSD) in an open-label trial. The present study was designed as a test of topiramate's efficacy as adjunctive therapy in a 7-week, randomized, double-blind, placebo-controlled trial.Forty male veterans with PTSD in a residential treatment program were randomized to flexible-dose topiramate or placebo augmentation. The primary outcome measures were PTSD symptom severity and global symptom improvement.Baseline Clinician-Administered PTSD Scale scores were 62.1 +/- 13.9 for placebo and 61.0 +/- 22.2 for topiramate. There was a high dropout rate from the study (55% topiramate; 25% placebo), with 40% of topiramate and 10% of placebo dropping because of adverse events (AEs). No significant treatment effects of topiramate versus placebo were observed for the primary treatment outcomes. Subjects reporting central nervous system-related AEs and with higher baseline severity of depression were more likely to discontinue because of AEs.Primary outcome measures failed to demonstrate a significant effect for topiramate over placebo; however, high dropout rate in the treatment group prohibits definitive conclusions about the efficacy of topiramate in this population.

    View details for DOI 10.1097/jcp.0b013e31815a43ee

    View details for Web of Science ID 000251181600017

    View details for PubMedID 18004136

  • Perceived self-efficacy and headache-related disability HEADACHE French, D. J., Holroyd, K. A., Pinell, C., Malinoski, P. T., O'Donnell, F., Hill, K. R. 2000; 40 (8): 647-656

    Abstract

    Headache-specific self-efficacy refers to patients' confidence that they can take actions that prevent headache episodes or manage headache-related pain and disability. According to social cognitive theory, perceptions of self-efficacy influence an individual's adaptation to persistent headaches by influencing cognitive, affective, and physiological responses to headache episodes as well as the initiation and persistence of efforts to prevent headache episodes.The objective of the present study was to construct and validate a brief measure of headache specific self-efficacy and to examine the relationship between self-efficacy and headache-related disability.A sample of 329 patients seeking treatment for benign headache disorders completed the Headache Management Self-Efficacy Scale and measures of headache-specific locus of control, coping, psychological distress, and headache-related disability. A subset of 262 patients also completed 4 weeks of daily headache recordings.As predicted, patients who were confident they could prevent and manage their headaches also believed that the factors influencing their headaches were potentially within their control. In addition, self-efficacy scores were positively associated with the use of positive psychological coping strategies to both prevent and manage headache episodes and negatively associated with anxiety. Multiple regression analyses revealed that headache severity, locus-of-control beliefs, and self-efficacy beliefs each explained independent variance in headache-related disability.

    View details for Web of Science ID 000089391300004

    View details for PubMedID 10971661

  • Psychosocial correlates and impact of chronic tension-type headaches HEADACHE Holroyd, K. A., Stensland, M., Lipchik, G. L., Hill, K. R., O'Donnell, F. S., Cordingley, G. 2000; 40 (1): 3-16

    Abstract

    To examine the psychosocial correlates of chronic tension-type headache and the impact of chronic tension-type headache on work, social functioning, and well-being.Two hundred forty-five patients (mean age = 37.0 years) with chronic tension-type headache as a primary presenting problem completed an assessment protocol as part of a larger treatment outcome study. The assessment included a structured diagnostic interview, the Medical Outcomes Study Short Form, Disability Days/Impairment Ratings, Recurrent Illness Impact Profile, Beck Depression Inventory, State-Trait Anxiety Inventory-Trait Form, Primary Care Evaluation for Mental Disorders, and the Hassles Scale Short Form. Comparisons were made with matched controls (N = 89) and, secondarily, with Medical Outcomes Study data for the general population, arthritis, and back problem samples.About two thirds of those with chronic tension-type headache recorded daily or near daily (> or =25 days per month) headaches with few (12%) recording headaches on less than 20 days per month. Despite the fact that patients reported that their headaches had occurred at approximately the present frequency for an average of 7 years, chronic tension-type headache sufferers were largely lapsed consulters (54% of subjects) or current consulters in primary care (81% of consulters). Significant impairments in functioning and well-being were evident in chronic tension-type headache and were captured by each of the assessment devices. Although headache-related disability days were reported by 74% of patients (mean = 7 days in previous 6 months), work or social functioning was severely impaired in only a small minority of patients. Sleep, energy level, and emotional well-being were frequently impaired with about one third of patients recording impairments in these areas on 10 or more days per month. Most patients with chronic tension-type headache continued to carry out daily life responsibilities when in pain, although role performance at times was clearly impaired by headaches and well-being was frequently impaired. Chronic tension-type headache sufferers were 3 to 15 times more likely than matched controls to receive a diagnosis of an anxiety or mood disorder with almost half of the patients exhibiting clinically significant levels of anxiety or depression. Affective distress and severity of headaches (Headache Index) were important determinants of headache impact/impairment.Chronic tension-type headache has a greater impact on individuals' lives than has generally been realized, with affective distress being an important correlate of impairment. If treatment is to remedy impairment in functioning, affective distress, as well as pain, thus needs to be addressed.

    View details for Web of Science ID 000085218500003

    View details for PubMedID 10759896

  • SERIOUS MENTAL-ILLNESS AND MORTALITY-RATES HOSPITAL AND COMMUNITY PSYCHIATRY Berren, M. R., Hill, K. R., Merikle, E., Gonzalez, N., Santiago, J. 1994; 45 (6): 604-605

    View details for Web of Science ID A1994NN39400017

    View details for PubMedID 8088743